Welcome Sandoz

We are excited to welcome new Bio Nebraska member, Sandoz.

Sandoz is a global leader in the generics and biosimilars markets with one of the broadest portfolios in the industry, reaching approximately 500 million patients every year in more than 100 markets. 

  • Generics, divided between standard generics (mainly oral solids) and complex generics (including injectables, respiratory and others). Biosimilars, where we are the global pioneer, with a rapidly growing pipeline now counting 24 molecules.
  • We are the established global leader in generic antibiotics, with 50-plus medicines serving more than 200 million patients per year. And we have a leading global program to combat antimicrobial resistance (AMR), taking a balanced, cross-sector approach to combatting this unprecedented global health threat. 
  • Our goal is simple: to ensure patients continue to receive the medicine they need, when and where they need it.